Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Harumi Nagayama"'
Autor:
Tatsuya Nakatani, Yasuro Kumeda, Shozo Yodoi, Harumi Nagayama, Kiyoshi Maekawa, Takayoshi Hamada, Shinya Nakatani, Hisako Fujii, Sosuke Kagitani, Minoru Yoshiyama, Yoshinori Sai, Ayumi Shintani, Yoshikazu Kato, Yoshihiro Tsujimoto, Tetsuo Shoji, Daijiro Kabata, Hisako Yoshida, Kenjiro Yamakawa, Mayumi Sakurai, Yoshiteru Ohno, Yasue Obi, Takayasu Matsumura, Kiyoshi Goto, Keiko Ota, Satoshi Sasaki, Masahito Imanishi, Shinichi Nishi, Shinichiro Ueda, Eiji Ishimura, Katsuhito Mori, Shigeichi Shoji, Masaaki Inaba, Kaori Shidara, Hideaki Yasuda, Masanori Emoto, K. Takahashi
Publikováno v:
Clin J Am Soc Nephrol
BACKGROUND AND OBJECTIVES: Vitamin D receptor activators and calcimimetics (calcium-sensing receptor agonists) are two major options for medical treatment of secondary hyperparathyroidism. A higher serum calcification propensity (a shorter T(50) valu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf4e5f58cfdeff3d4ea07e93684bcc41
https://doi.org/10.2215/cjn.16601020
https://doi.org/10.2215/cjn.16601020
Autor:
Tomonori Kimura, Takehiro Tamai, Yoshitaka Isaka, Yoshitsugu Obi, Hiromi Rakugi, Keiko Yasuda, Harumi Nagayama, Kazusei Uematsu, Koichi Sasaki, Terumasa Hayashi, Motoki Ohno, Takahiro Nishide
Publikováno v:
Circulation journal : official journal of the Japanese Circulation Society. 80(4)
Background There is a paucity of studies on whether early referral (ER) to nephrologist could reduce cardiovascular mortality on dialysis, and the length of pre-dialysis nephrological care needed to reduce mortality on dialysis. Methods and results A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05768a7bb701a314420ba1dbce9b6c4e
https://pubmed.ncbi.nlm.nih.gov/26876973
https://pubmed.ncbi.nlm.nih.gov/26876973
Autor:
Senji Okuno, Shigeichi Shoji, Tomoyuki Yamakawa, Shinsuke Yamada, Eiji Ishimura, Masaaki Inaba, Masafumi Kurajoh, Yasuo Imanishi, Harumi Nagayama, Yoshiki Nishizawa
Publikováno v:
Osteoporosis International. 22:923-930
In cinacalcet treatment of hemodialysis (HD) patients with secondary hyperparathyroidism (SHPT), not only intact parathyroid hormone (I-PTH), whole PTH (W-PTH), and bone markers, but also W-PTH/I-PTH ratio as proportion of active PTH(1–84) molecule
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d44fa6362dadf396830979e3868ce841
https://doi.org/10.1007/s00198-010-1262-x
https://doi.org/10.1007/s00198-010-1262-x
Autor:
Eiji Ishimura, Harumi Nagayama, Masaaki Inaba, Shuji Okazaki, Reiko Okabe, Yoshiki Nishizawa, Masanori Emoto
Publikováno v:
Biomedicine & Pharmacotherapy. 63:236-240
Aims To compare glycated albumin (GA) with glycated hemoglobin (HbA1c) as an indicator of glycemic control in hemodialysis patients with diabetes mellitus (DM), based on relationships with plasma glucose (PG) after overnight fasting and during 75 g o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e516b5cd02eadbea7837c2f061a50757
https://doi.org/10.1016/j.biopha.2008.04.002
https://doi.org/10.1016/j.biopha.2008.04.002
Autor:
Shigeichi Shoji, Shinsuke Yamada, Senji Okuno, Harumi Nagayama, Masaaki Inaba, Yasuo Imanishi, Eiji Ishimura
Publikováno v:
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 25(2)
Control of phosphate is the most critical in the treatment of chronic kidney disease with mineral and bone disorder (CKD-MBD). Because calcium-containing phosphate binder to CKD patients is known to induce adynamic bone disease with ectopic calcifica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abd29cfad52d86fd94108a53ad295f9f
https://pubmed.ncbi.nlm.nih.gov/25556148
https://pubmed.ncbi.nlm.nih.gov/25556148